Robert D'Ippolito

Robert D’Ippolito received his PhD from the University of Virginia under the mentorship of Dr. Donald F. Hunt, where he focused on implementing a novel protein digestion strategy for bispecific antibodies using a nonspecific enzyme reactor. After defending his dissertation, D’Ippolito expanded his proteomic capabilities to support the NCI RAS Initiative at the Frederick National Laboratory for Cancer Research, addressing key biological questions related to the RAS signaling pathway. Currently, D’Ippolito is a Senior Scientist at Merck, where he applies his mass spectrometry expertise to advance vaccine development.